FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells

被引:73
作者
Rippo, MR [1 ]
Moretti, S
Vescovi, S
Tomasetti, M
Orecchia, S
Amici, G
Catalano, A
Procopio, A
机构
[1] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, I-60100 Ancona, Italy
[2] Italian Natl Res Ctr Aging, Lab Cytol, I-860124 Ancona, Italy
[3] S Antonio & Biagio Hosp, Dept Anat Pathol, I-15100 Alessandria, Italy
[4] Pediat Hosp G Salesi, I-60100 Ancona, Italy
关键词
malignant mesothelioma; Fas; TRAIL; FLIP; caspase-8; apoptosis;
D O I
10.1038/sj.onc.1208051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumors have developed several forms of resistance to receptor-induced cell death. Here, we show that malignant mesothelial (MM) cell lines as well as primary MM cells and normal mesothelial (NM) cells express Fas and TNF-related apoptosis-inducing ligand (TRAIL) receptors DR4 and DR5. We found that, although Fas expression levels are comparable, only MM cells are resistant to cell death. Furthermore, MM cells show resistance to TRAIL-induced apoptosis. Caspase-8 (FLICE) is not activated by death receptors triggering in malignant cells whereas it is well activated by nonreceptor stimuli, such as UV radiation. We found that FLIP (FLICE-Inhibitory Protein) is constitutively expressed in all MM cell lines and is more expressed in primary MM cells than in NM cells. Knockdown of FLIP expression in MM cell lines, by a FLIPsiRNA, re-established the normal response to apoptosis induced by Fas or DR4/DR5, which was blocked by pretreatment with the caspase-8 inhibitor z-IETD-fmk. These results indicate that MM cells develop an intrinsic resistance to apoptosis induced by death receptors upregulating the expression of the antiapoptotic protein c-FLIP.
引用
收藏
页码:7753 / 7760
页数:8
相关论文
共 39 条
[1]   Pathology of malignant mesothelioma [J].
Attanoos, RL ;
Gibbs, AR .
HISTOPATHOLOGY, 1997, 30 (05) :403-418
[2]   Rel/NF-κB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1 [J].
Bernard, D ;
Quatannens, B ;
Vandenbunder, B ;
Abbadie, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27322-27328
[3]   Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells [J].
Bradley, M ;
Zeytun, A ;
Rafi-Janajreh, A ;
Nagarkatti, PS ;
Nagarkatti, M .
BLOOD, 1998, 92 (11) :4248-4255
[4]  
CARBONE M, 1994, ONCOGENE, V9, P1781
[5]   Regulation of apoptosis by lethal cytokines in human mesothelial cells [J].
Catalan, MP ;
Subirá, D ;
Reyero, A ;
Selgas, R ;
Ortiz-Gonzalez, A ;
Egido, J ;
Ortiz, A .
KIDNEY INTERNATIONAL, 2003, 64 (01) :321-330
[6]   The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors [J].
Djerbi, M ;
Screpanti, V ;
Catrina, AI ;
Bogen, B ;
Biberfeld, P ;
Grandien, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :1025-1031
[7]   Defective death receptor signaling as a cause of tumor immune escape [J].
French, LE ;
Tschopp, J .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (01) :51-55
[8]   The TRAIL to selective tumor death [J].
French, LE ;
Tschopp, J .
NATURE MEDICINE, 1999, 5 (02) :146-147
[9]   Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity [J].
Frost, P ;
Ng, CP ;
Belldegrun, A ;
Bonavida, B .
CELLULAR IMMUNOLOGY, 1997, 180 (01) :70-83
[10]   Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].
Hahne, M ;
Rimoldi, D ;
Schroter, M ;
Romero, P ;
Schreier, M ;
French, LE ;
Schneider, P ;
Bornand, T ;
Fontana, A ;
Lienard, D ;
Cerottini, JC ;
Tschopp, J .
SCIENCE, 1996, 274 (5291) :1363-1366